Panaxea PC2 helps decrease PSA count and promotes apoptosis, has antiangiogenic, cytostatic and cytotoxic effects. PC2 contains Ganoderma lucidum, has an ability to modulate the androgen receptor activation of transcription from prostate-specific antigen promoter in PCa cells. PC2 is especially designed for prostate cancer patients.